Plasma prostaglandin concentration and abortifacient effectiveness of a single insertion of a 3 mg 15(S)-methyl-prostaglandin F2a methyl ester vaginal suppository

This publication has 11 references indexed in Scilit:

• The Effects of Intramuscular Injections of 15(S)-15-Methyl Prostaglandin F2α in Failed Abortions**Supported by Grant 73049 from The Rockefeller Foundation and by The Upjohn Company, Kalamazoo, Mich.††Presented at the Ninth World Congress on Fertility and Sterility and the Thirty-Third Annual Meeting of The American Fertility Society, April 12 to 16, 1977, Miami Beach, Fla.
  Fertility and Sterility, 1977
• Development of a vaginal suppository suitable for single administration for interruption of second trimester pregnancy
  Contraception, 1977
• The abortifacient effects of a newly developed vaginal silastic device impregnated with an 0.5% concentration of 15(s)-15-methyl-prostaglandin F2α methyl ester in the first trimester
  Contraception, 1976
• Luteolytic and abortifacient effects of serial intramuscular injections of 15(S)-15-methyl-prostaglandin F2α in early pregnancy
  American Journal of Obstetrics and Gynecology, 1976
• A radioimmunoassay of 15 (S) 15 methyl prostaglandin F2α
  Prostaglandins, 1975
• Midtrimester abortion induced by serial intramuscular injections of 15(S)-15-methyl-prostaglandin F2α
  American Journal of Obstetrics and Gynecology, 1975
• Induction of midtrimester abortion by serial intravaginal administration of 15(S)-15-methyl-prostaglandin F2α (THAM) suppositories
  Prostaglandins, 1975
• Reassessment of systemic administration of prostaglandins for induction of midtrimester abortion
  Prostaglandins, 1974
• Response of the midpregnant human uterus to systemic administration of 15(S)-15-methyl-prostaglandin F2α
  Prostaglandins, 1972
• NOVEL PROSTAGLANDIN SYNTHESES
  Annals of the New York Academy of Sciences, 1971